Rating Change
Cantor Fitzgerald reiterated its Overweight rating on MiMedx Group, Inc. (NASDAQ:MDXG) on August 17, 2026.
reiterateNASDAQ:MDXG
Cantor Fitzgerald Reiterates Overweight Rating on MiMedx Group, Inc. (MDXG)
Cantor Fitzgerald reiterated its Overweight rating on MiMedx Group, Inc. (NASDAQ:MDXG) on August 17, 2026.
At publication ·
What changed
MiMedx Group, Inc. (NASDAQ:MDXG) · reiterate
- Firm
- Cantor Fitzgerald
- Rating
- Overweight to Overweight
- Price at event
- $4.19
- Market capitalization
- $1.1B
At a glance
Key takeaways
- Cantor Fitzgerald reiterated an Overweight rating on MiMedx Group (MDXG) on August 17, 2026, with the stock trading at $4.19 and a market capitalization of $1.1 billion.
Market Context
MiMedx Group, Inc. operates in the Healthcare sector. The stock currently trades at $4.19 with a market capitalization of $1.1B.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MiMedx Group, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for MiMedx Group, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 17, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Apr 30, 2026 | Citizens | Market Outperform | N/A |
| Apr 20, 2026 | Citizens | Market Outperform | N/A |
| Apr 17, 2026 | Craig-Hallum | Buy | N/A |
| Feb 23, 2026 | Citizens | Market Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View MDXG Stock Page
Frequently Asked Questions
What does the Overweight rating mean for MDXG?
A rating of Overweight from Cantor Fitzgerald reflects the analyst's outlook on MiMedx Group, Inc. (NASDAQ:MDXG). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MDXG forecast page.